Design of Caspase Inhibitors as Potential Clinical Agents

Simons, Claire (Series edited by)/ Smith, H. John (Series edited by)/ O'Brien, Tom (Edited by)/ Linton, Steven D. (Edited by)

ISBN 10: 1420045407 / ISBN 13: 9781420045406

Editore: CRC Pr I Llc, 2008

Riguardo questo articolo

1st edition. 327 pages. 9.45x6.34x0.75 inches. In Stock.

Codice articolo __1420045407

Dati bibliografici

• Titolo: Design of Caspase Inhibitors as Potential Clinical Agents
• Editore: CRC Pr I Llc
• Data di pubblicazione: 2008
• Lingua: Inglese
• ISBN 10: 1420045407
• ISBN 13: 9781420045406
• Rilegatura: Hardcover
• Condizione: Brand New
• Peso: 0,59 chilogrammi

Descrizione articolo

Riassunto

Presents the Therapeutic Potential for Caspase Inhibitors: Present and Future

Caspases represent one of the most specific protease families described to date. These extremely important enzymes are crucial to the destruction of aberrant cells – the body’s self-protection mechanism for warding off the growth of abnormal cells, many of which can promote cancer. Design of Caspase Inhibitors as Potential Clinical Agents introduces cutting-edge evidence regarding caspases’ role in pro-inflammatory responses. New research now shows that the inhibition of caspase function is a critical component for the treatment of many diseases, including:

• Arthritic and neurological disorders





• Lung disease





• Hereditary fever syndromes





• Inflammatory bowel and skin diseases





• Sepsis





• Liver fibrosis

Outlines Efforts to Develop Molecule Inhibitors for Caspase Activity Transformation

Under the editorial guidance of authoritative inflammatory disease, small molecule discovery, and apoptosis researchers, the book organizes the wide array of caspase literature into one convenient resource. It also summarizes the relative difficulty of transitioning a caspase small molecule inhibitor from the lab to the clinic and suggests approaches to circumvent this difficulty. Taking a novel, yet core approach to disease treatment, this seminal work sets the stage to combat a slew of debilitating diseases through groundbreaking drug development.

Informazioni sull?autore

Tom O’Brien, Steven D. Linton